Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
17.53
-0.04 (-0.23%)
At close: Feb 9, 2026, 4:00 PM EST
17.18
-0.35 (-2.00%)
After-hours: Feb 9, 2026, 5:56 PM EST
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $534.07 million as of February 9, 2026. Its market cap has increased by 11.36% in one year.
Market Cap
534.07M
Enterprise Value
-141.97M
1-Year Change
11.36%
Ranking
Category
Stock Price
$17.53
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $534.07M, an increase of 38.60%. That is a compound annual growth rate of 5.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 534.07M | -13.90% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 546.82M |
| Evommune | 535.59M |
| Solid Biosciences | 534.46M |
| Forte Biosciences | 531.56M |
| Tenax Therapeutics | 527.41M |
| Lexeo Therapeutics | 525.51M |
| Alto Neuroscience | 523.16M |
| Gossamer Bio | 523.09M |